The study is raising fresh questions about the efficacy of the broad-spectrum antiviral medication originally developed to treat Ebola and approved in May for emergency use on Covid-19 patients. And although patients on remdesivir did report fewer severe symptoms of Covid-19 overall, they also experienced more minor to moderate symptoms and side effects. AdvertisementAll the patients in the study were at least 12 years old and had been hospitalised with moderate Covid-19 pneumonia. One received a 10-day course of remdesivir and the second a five-day course, while the third was treated without the drug. They raised questions about whether some patients get more benefits from remdesivir than others and whether it matters if patients receive remdesivir and steroids together.

Source: Daily Nation August 25, 2020 12:00 UTC